Macroview Investment Management LLC Crispr Therapeutics Ag Transaction History

Macroview Investment Management LLC

  • $94.5 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
SELL
$60.67 - $89.12 $6,855 - $10,070
-113 Reduced 53.05%
100 $6,000
Q4 2023

Jan 30, 2024
BUY
$38.62 - $72.18 $4,364 - $8,156
113 Added 113.0%
213 $13,000
Q3 2023

Oct 26, 2023
SELL
$45.39 - $59.0 $680 - $885
-15 Reduced 13.04%
100 $4,000
Q2 2023

Jul 13, 2023
BUY
$43.47 - $67.77 $4,347 - $6,777
100 Added 666.67%
115 $6,000
Q1 2022

May 02, 2022
BUY
$53.19 - $79.24 $797 - $1,188
15 New
15 $1,000

Others Institutions Holding CRSP

# of Institutions
484
Shares Held
64.1M
Call Options Held
1.64M
Put Options Held
1.93M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.93B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email